Follow the Avricore Health Inc. stock price and the full directors' dealings record of the company, a listed equity based in Canada. Shares trade on the CA market, under the oversight of SEDI. Market capitalisation: €7.6m. The latest transaction was filed on 28 August 2026 (50 - Grant of options). Among the most active insiders: Teahen, Thomas Wilfrid. All data is accessible without an account.
22
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
55Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,733 of 29,063 companies
23.5
score / 100
Value
15
Quality
32
FCF yld-8.0%
Earn yld-16%
EV/EBITDA·
ROE-185%
Gross mgn45%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Avricore Health Inc. es una empresa canadiense centrada en el sector de la salud. Se especializa en el desarrollo de soluciones innovadoras de diagnóstico y atención médica.